BiotechTube
Advamedica

Advamedica

San Diego, United States· Est.
advamedica.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Advamedica is a private, commercial-stage medical device company leveraging a proprietary biomaterials platform to develop and commercialize hemostatic and wound care products. Its flagship products, including Axiostat and Maxiocel, have gained regulatory clearances in the US and over 40 other countries, targeting the cardiovascular and trauma care markets. The company is backed by notable venture capital firms and maintains a strategic presence in key US innovation hubs like Cambridge, Massachusetts, and San Diego, California.

CardiovascularTraumaWound Care

Technology Platform

Proprietary biomaterials platform based on chitosan, featuring Protonated Bioadhesive Technology (PBT) for strong tissue adhesion and hemostatic control.

Opportunities

The global hemostasis and advanced wound care markets are large and growing, driven by surgical volumes, trauma, and chronic diseases.
Recent US FDA clearances and HCPCS coding for Maxiocel provide a direct pathway for reimbursement and significant growth in the US healthcare system.
The company's platform allows for potential expansion into new biomaterial-based device applications.

Risk Factors

Intense competition from large, established medtech companies with greater sales and marketing resources poses a significant commercial challenge.
Navigating complex and variable reimbursement landscapes, particularly in the US, is critical for financial success.
Market adoption requires displacing entrenched products and convincing clinicians of the superior value proposition.

Competitive Landscape

Advamedica competes in the hemostat market against major players like Johnson & Johnson (Ethicon), Baxter, Integra LifeSciences, and Z-Medica. In wound care, it faces competition from Smith & Nephew, 3M, ConvaTec, and many others. Its differentiation lies in its proprietary chitosan-based technology, which offers strong bioadhesion and antimicrobial properties compared to traditional gelatin or collagen-based products.

More companies in Drug Delivery & Formulation →More companies in United States →